toxicity

FDA rejects Gilead's would-be blockbuster filgotinib

With the FDA asking to see data from an ongoing clinical trial, Gilead is unlikely to be able to refile until toward the middle of next year.

Nick Paul Taylor Aug 19, 2020 4:22am

Newly formed Ncardia inks iPSC licensing deal with Evotec

Dec 6, 2017 8:00am

Toxicity knocks Ardelyx's hyperkalemia hopes back to preclinic

Nov 21, 2017 9:15am

MIT team creates wearable nanotube toxic gas detectors

Jul 5, 2016 10:49am